Erasmus School of Health Policy & Management
External PhD candidate | Health Technology Assessment (HTA)
- vandelaar@eshpm.eur.nl
More information
Work
- Celine J. Van De Laar, Martijn A.H. Oude Voshaar, Peter Ten Klooster, Danyta I. Tedjo, Reinhard Bos, Tim Jansen, A. Willemze, Grada A. Versteeg, Y. P.M. Goekoop-Ruiterman, Eric Jan Kroot & Mart Van De Laar (2024) - PERFECTRA: A pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs - RMD Open, 10 (2) - doi: 10.1136/rmdopen-2024-004291 - [link]
- Celine Johanna van de Laar, Carly A. Janssen, Matthijs Janssen, Martijn A.H. Oude Voshaar, J. A.L. Maiwenn & Mart A.F.J. van de Laar (2022) - Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients - PLoS ONE, 17 (1 January) - doi: 10.1371/journal.pone.0261940 - [link]
